First-in-human Study of SAR443765 in Healthy Participants and in Asthmatic Participants

NCT05366764 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: SAR443765
DRUG: Placebo
DRUG: Salbutamol or levosalbutamol

Sponsor

Sanofi